Skip to main content

Find Clinical Trials

Home
Conditions
Harboring EGFR Common Mutation

Clinical trial condition

Harboring EGFR Common Mutation

Explore clinical trials studying Harboring EGFR Common Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Harboring EGFR Common Mutation trial results

Active, Not Recruiting

JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations

NCT06391944

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Li Zhang Beijing, Beijing Municipality, China

View Trial Details